Virus News and Research

Latest Virus News and Research

UK’s first Centre for Phage Research highlights Actiphage in the KTN UK Phage Innovation Showcase

UK’s first Centre for Phage Research highlights Actiphage in the KTN UK Phage Innovation Showcase

18 May 2023
Post-COVID condition varies by variant and vaccination status

Post-COVID condition varies by variant and vaccination status

17 May 2023
Novel antibodies target human receptors to neutralize SARS-CoV-2 variants and future sarbecoviruses

Novel antibodies target human receptors to neutralize SARS-CoV-2 variants and future sarbecoviruses

17 May 2023
Are masks effective in the protection against COVID-19?

Are masks effective in the protection against COVID-19?

17 May 2023
Nemours Children's Health selected to conduct first gene therapy clinical trial for Morquio A syndrome

Nemours Children's Health selected to conduct first gene therapy clinical trial for Morquio A syndrome

16 May 2023
Cancer patients can initiate SARS-CoV-2 vaccination three months after bone marrow transplant

Cancer patients can initiate SARS-CoV-2 vaccination three months after bone marrow transplant

16 May 2023
Study identifies two novel highly pathogenic avian influenza viruses (H5N1) clade 2.3.4.4b.2

Study identifies two novel highly pathogenic avian influenza viruses (H5N1) clade 2.3.4.4b.2

16 May 2023
The discovery of a novel orthonairovirus from Dermacentor silvarum ticks near the China–North Korea border

The discovery of a novel orthonairovirus from Dermacentor silvarum ticks near the China–North Korea border

16 May 2023
Novel 'CLEVER' method accelerates engineering and genetic study of SARS-CoV-2 and its variants

Novel 'CLEVER' method accelerates engineering and genetic study of SARS-CoV-2 and its variants

16 May 2023
Insights from blood donors: Serosurveillance reveals population insights for targeted health interventions

Insights from blood donors: Serosurveillance reveals population insights for targeted health interventions

16 May 2023
Clinical trial of a combination treatment shows great promise for patients with glioblastoma

Clinical trial of a combination treatment shows great promise for patients with glioblastoma

15 May 2023
Phase 1 trial of experimental universal influenza vaccine begins enrolling volunteers

Phase 1 trial of experimental universal influenza vaccine begins enrolling volunteers

15 May 2023
Combination approach is safe, improves survival outcomes in a subset of glioblastoma patients

Combination approach is safe, improves survival outcomes in a subset of glioblastoma patients

15 May 2023
Alcohol-based disinfectants can effectively protect against monkeypox viruses

Alcohol-based disinfectants can effectively protect against monkeypox viruses

15 May 2023
SARS-CoV-2 variants show altered glycan processing

SARS-CoV-2 variants show altered glycan processing

15 May 2023
Novel arterivirus discovered in Amazonian rodents unveiling a potential viral spillover threat

Novel arterivirus discovered in Amazonian rodents unveiling a potential viral spillover threat

14 May 2023
AI used to build a 3D model of the Commander complex

AI used to build a 3D model of the Commander complex

11 May 2023
People with obesity may need more frequent booster vaccines to maintain their immunity

People with obesity may need more frequent booster vaccines to maintain their immunity

11 May 2023
New antimicrobial coating material effectively kills bacteria and viruses

New antimicrobial coating material effectively kills bacteria and viruses

11 May 2023
The crisis is officially ending, but covid confusion lives on

The crisis is officially ending, but covid confusion lives on

11 May 2023

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback